THYROCARE TECH LTD

Thyrocare Technologies Limited held its Q1 FY27 earnings conference call on July 23, 2026, where management discussed the company's growth and strategic initiatives. CEO Rahul Guha highlighted the significant expansion of the pathology business, which grew by 26% in Q1 FY27, and noted the increase in the active franchise network to over 11,700. The company received several awards for its diagnostic services, reflecting its commitment to quality and customer trust. Management reported a consolidated revenue growth of 24.3% year-on-year, driven by strong performance in both the franchisee and partnership segments. The introduction of specialty diagnostics was emphasized as a key growth area, with plans to enhance accessibility and affordability. CFO Vikram Gupta shared financial highlights, including a 34% increase in EBITDA and a profit after tax of INR 51.3 crores. The call concluded with management reiterating its focus on maintaining quality and expanding its market presence.

Management emphasized strong growth and strategic advancements in the business.